These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2653698)

  • 21. [The effectiveness of enoxacin for the treatment of complicated urinary tract infection].
    Germinario C; Quarto M; Viggiani N; Schena FP
    Riv Eur Sci Med Farmacol; 1992; 14(5):347-51. PubMed ID: 1308966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Enoxacin].
    Gava R; Beltrami GC; Grezzana L
    G Clin Med; 1989; 70(8-9):537-41. PubMed ID: 2509272
    [No Abstract]   [Full Text] [Related]  

  • 23. [The antimicrobial activity of fluoroquinolone agents against pathogenic organisms in respiratory tract infections and its clinical effect].
    Akiyama M; Takahashi A; Nagatake T; Yamashita H; Yoshida T; Rikitomi N; Ohishi K; Tanaka H; Morito T; Utsunomiya Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Sep; 28(9):1174-81. PubMed ID: 2176251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enoxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Henwood JM; Monk JP
    Drugs; 1988 Jul; 36(1):32-66. PubMed ID: 3063494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Enoxacin in the treatment of bacterial prostato-cystitis].
    Mantovani F; Mascheroni E; Dal Prà ML; Montanari E; Mandressi A; Austoni E; Pisani E
    Arch Ital Urol Nefrol Androl; 1989 Sep; 61(3):243-8. PubMed ID: 2529640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens.
    Naber KG; Well M; Hollauer K; Kirchbauer D; Witte W
    Chemotherapy; 1998; 44(2):77-84. PubMed ID: 9551236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical studies on enoxacin in urinary tract infection].
    Nagai N; Kaneko S; Akiyama T; Kurita T; Iguchi M; Kataoka K
    Hinyokika Kiyo; 1988 Jul; 34(7):1283-91. PubMed ID: 3051955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.
    Balfour JA; Todd PA; Peters DH
    Drugs; 1995 May; 49(5):794-850. PubMed ID: 7601015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparison of fluoroquinolones (norfloxacin, enoxacin, ofloxacin) in the therapy of lower urinary tract infections].
    Tizzani A; Casetta G; Cavallini A; Piana P
    Minerva Urol Nefrol; 1990; 42(2):81-4. PubMed ID: 2392745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of treatment of uncomplicated urogenital gonorrhoea with enoxacin compared with ceftriaxone.
    Calderón E; Conde-Glez C; Echaniz G; Arredondo JL; Olvera J; Hirata C; Villafaña M
    Int J Clin Pharmacol Res; 1988; 8(4):247-51. PubMed ID: 3141301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-dose enoxacin compared with 3-day treatment for urinary tract infection.
    Backhouse CI; Matthews JA
    Antimicrob Agents Chemother; 1989 Jun; 33(6):877-80. PubMed ID: 2764538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Enoxacin in the treatment of male genital infections in patients with antisperm autoimmune pathology].
    Lombardo F; Gandini L; Alfano P; Anticoli Borza L; Lenzi A; Dondero F
    Arch Ital Urol Nefrol Androl; 1990 Sep; 62(3):361-8. PubMed ID: 2148024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use.
    Paton JH; Reeves DS
    Drugs; 1988 Aug; 36(2):193-228. PubMed ID: 3053126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.
    Croom KF; Goa KL
    Drugs; 2003; 63(24):2769-802. PubMed ID: 14664657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pharmacokinetic, bacteriological, and clinical studies on panipenem/betamipron in children].
    Tajima T; Nishimura S; Higa A; Kondo Y; Negishi S; Hata M; Abe T; Fujii R
    Jpn J Antibiot; 1992 Mar; 45(3):293-300. PubMed ID: 1512926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
    Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacokinetic, bacteriological and clinical studies on cefpodoxime proxetil in the field of pediatrics].
    Akita H; Sato Y; Iwata S; Sunakawa K
    Jpn J Antibiot; 1989 Jul; 42(7):1547-60. PubMed ID: 2810729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the fluoroquinolones.
    Guay DR
    Pharmacotherapy; 1992; 12(6 Pt 2):71S-85S. PubMed ID: 1480503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Enoxacin for type III A prostatitis: a clinical observation].
    Chen Z; Zhou XC; Chen ZQ; Ye ZQ; Deng RJ
    Zhonghua Nan Ke Xue; 2010 Mar; 16(3):258-60. PubMed ID: 20369557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enoxacin for the treatment of urinary tract infection.
    Bailey RR; Peddie BA
    N Z Med J; 1985 Apr; 98(777):286-8. PubMed ID: 3857511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.